These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 23209807)

  • 1. TBK1 kinase addiction in lung cancer cells is mediated via autophagy of Tax1bp1/Ndp52 and non-canonical NF-κB signalling.
    Newman AC; Scholefield CL; Kemp AJ; Newman M; McIver EG; Kamal A; Wilkinson S
    PLoS One; 2012; 7(11):e50672. PubMed ID: 23209807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic insights into the interactions of NAP1 with the SKICH domains of NDP52 and TAX1BP1.
    Fu T; Liu J; Wang Y; Xie X; Hu S; Pan L
    Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11651-E11660. PubMed ID: 30459273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A NIK-SIX signalling axis controls inflammation by targeted silencing of non-canonical NF-κB.
    Liu Z; Mar KB; Hanners NW; Perelman SS; Kanchwala M; Xing C; Schoggins JW; Alto NM
    Nature; 2019 Apr; 568(7751):249-253. PubMed ID: 30894749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LATS2 inhibits the activity of NF-κ B signaling by disrupting the interaction between TAK1 and IKKβ.
    Yao F; Zhou W; Zhong C; Fang W
    Tumour Biol; 2015 Sep; 36(10):7873-9. PubMed ID: 25946971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Src Promotes Metastasis of Human Non-Small Cell Lung Cancer Cells through Fn14-Mediated NF-κB Signaling.
    Wang W; Liu F; Wang C; Wang C; Tang Y; Jiang Z
    Med Sci Monit; 2018 Mar; 24():1282-1294. PubMed ID: 29500337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy-Independent Lysosomal Targeting Regulated by ULK1/2-FIP200 and ATG9.
    Goodwin JM; Dowdle WE; DeJesus R; Wang Z; Bergman P; Kobylarz M; Lindeman A; Xavier RJ; McAllister G; Nyfeler B; Hoffman G; Murphy LO
    Cell Rep; 2017 Sep; 20(10):2341-2356. PubMed ID: 28877469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic recruitment and activation of ALS-associated TBK1 with its target optineurin are required for efficient mitophagy.
    Moore AS; Holzbaur EL
    Proc Natl Acad Sci U S A; 2016 Jun; 113(24):E3349-58. PubMed ID: 27247382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Evaluation of Nuclear Factor-κΒ Expression Patterns in Non-Small Cell Lung Cancer.
    Giopanou I; Lilis I; Papaleonidopoulos V; Marazioti A; Spella M; Vreka M; Papadaki H; Stathopoulos GT
    PLoS One; 2015; 10(7):e0132527. PubMed ID: 26147201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CNK1 promotes invasion of cancer cells through NF-kappaB-dependent signaling.
    Fritz RD; Radziwill G
    Mol Cancer Res; 2010 Mar; 8(3):395-406. PubMed ID: 20197385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of autophagy, NF-κB signaling, and cell viability by miR-124 in
    Mehta AK; Hua K; Whipple W; Nguyen MT; Liu CT; Haybaeck J; Weidhaas J; Settleman J; Singh A
    Sci Signal; 2017 Sep; 10(496):. PubMed ID: 28900044
    [No Abstract]   [Full Text] [Related]  

  • 11. FIP200 controls the TBK1 activation threshold at SQSTM1/p62-positive condensates.
    Schlütermann D; Berleth N; Deitersen J; Wallot-Hieke N; Friesen O; Wu W; Stuhldreier F; Sun Y; Berning L; Friedrich A; Mendiburo MJ; Peter C; Wiek C; Hanenberg H; Stefanski A; Stühler K; Stork B
    Sci Rep; 2021 Jul; 11(1):13863. PubMed ID: 34226595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAB3 overexpression promotes cell proliferation in non-small cell lung cancer and mediates chemoresistance to CDDP in A549 cells via the NF-κB pathway.
    Chen J; Gu J; Feng J; Liu Y; Xue Q; Ni T; Wang Z; Jia L; Mao G; Ji L
    Tumour Biol; 2016 Mar; 37(3):3851-61. PubMed ID: 26476534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer.
    Kim J; McMillan E; Kim HS; Venkateswaran N; Makkar G; Rodriguez-Canales J; Villalobos P; Neggers JE; Mendiratta S; Wei S; Landesman Y; Senapedis W; Baloglu E; Chow CB; Frink RE; Gao B; Roth M; Minna JD; Daelemans D; Wistuba II; Posner BA; Scaglioni PP; White MA
    Nature; 2016 Oct; 538(7623):114-117. PubMed ID: 27680702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of NF-κB inducing kinase underlies constitutive NF-κB activation in lung cancer cells.
    Saitoh Y; Martínez Bruyn VJ; Uota S; Hasegawa A; Yamamoto N; Imoto I; Inazawa J; Yamaoka S
    Lung Cancer; 2010 Dec; 70(3):263-70. PubMed ID: 20338663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC).
    Zhao Q; Yue J; Zhang C; Gu X; Chen H; Xu L
    Oncotarget; 2015 Oct; 6(30):29335-46. PubMed ID: 26336823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRAF3 controls activation of the canonical and alternative NFkappaB by the lymphotoxin beta receptor.
    Bista P; Zeng W; Ryan S; Bailly V; Browning JL; Lukashev ME
    J Biol Chem; 2010 Apr; 285(17):12971-8. PubMed ID: 20185819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of p33(ING1), p53, and autophagy-related gene Beclin1 in patients with non-small cell lung cancer.
    Liu J; Lin Y; Yang H; Deng Q; Chen G; He J
    Tumour Biol; 2011 Dec; 32(6):1113-21. PubMed ID: 21779982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer.
    Zhang D; Jin X; Wang F; Wang S; Deng C; Gao Z; Guo C
    Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tribbles 2 (Trib2) is a novel regulator of toll-like receptor 5 signaling.
    Wei SC; Rosenberg IM; Cao Z; Huett AS; Xavier RJ; Podolsky DK
    Inflamm Bowel Dis; 2012 May; 18(5):877-88. PubMed ID: 22271508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-κB Participates in the Stem Cell Phenotype of Ovarian Cancer Cells.
    Gonzalez-Torres C; Gaytan-Cervantes J; Vazquez-Santillan K; Mandujano-Tinoco EA; Ceballos-Cancino G; Garcia-Venzor A; Zampedri C; Sanchez-Maldonado P; Mojica-Espinosa R; Jimenez-Hernandez LE; Maldonado V
    Arch Med Res; 2017 May; 48(4):343-351. PubMed ID: 28886875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.